EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

Olivia S Shin, Stephanie R Monticelli, Christy K Hjorth, Vladlena Hornet, Michael Doyle, Dafna Abelson, Ana I Kuehne, Albert Wang, Russell R Bakken, Akaash K Mishra, Marissa Middlecamp, Elizabeth Champney und 15 weitere

Cell Reports · 2024-07 · 43 (7) · 114502

DOI: 10.1016/j.celrep.2024.114502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-07. Verfasst von Olivia S Shin und 26 weiteren Autor:innen. Beteiligte Einrichtung: Adimab, LLC, Lebanon, NH 03766, USA. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Crimean, Hemorrhagic Fever Virus, Crimean-Congo, Antibodies, Viral. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoAntibodies, ViralHumansAnimalsMiceSurvivorsAntibodies, NeutralizingFemaleGlycoproteinsEpitopes

Stichwörter der Autor:innen

CCHFVCP: ImmunologyCrimean-Congo hemorrhagic fever virusGP38Nairoviridaeantibody therapeuticshuman monoclonal antibodytickborneviral glycoprotein

Substanzen

Antibodies, ViralAntibodies, NeutralizingGlycoproteinsEpitopes

Autor:innen und Institutionen

  • Adimab, LLC, Lebanon, NH 03766, USA.
  • U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA; Geneva Foundation, Tacoma, WA 98042, USA.
  • Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
  • Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
  • U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Shin, O. S., Monticelli, S. R., Hjorth, C. K., Hornet, V., Doyle, M., Abelson, D., Kuehne, A. I., Wang, A., Bakken, R. R., Mishra, A. K., Middlecamp, M., Champney, E., Stuart, L., Maurer, D. P., Li, J., Berrigan, J., Barajas, J., Balinandi, S., Lutwama, J. J., …, & McLellan, J. S. (2024). Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Reports, 43(7), 114502. https://doi.org/10.1016/j.celrep.2024.114502

Vancouver

Shin OS, Monticelli SR, Hjorth CK, Hornet V, Doyle M, Abelson D, et al. Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Reports. 2024;43(7):114502. doi:10.1016/j.celrep.2024.114502

BibTeX
@article{Shin2024,
  author = {Shin, Olivia S and Monticelli, Stephanie R and Hjorth, Christy K and Hornet, Vladlena and Doyle, Michael and Abelson, Dafna and Kuehne, Ana I and Wang, Albert and Bakken, Russell R and Mishra, Akaash K and Middlecamp, Marissa and Champney, Elizabeth and Stuart, Lauran and Maurer, Daniel P and Li, Jiannan and Berrigan, Jacob and Barajas, Jennifer and Balinandi, Stephen and Lutwama, Julius J and Lobel, Leslie and Zeitlin, Larry and Walker, Laura M and Dye, John M and Chandran, Kartik and Herbert, Andrew S and Pauli, Noel T and McLellan, Jason S},
  title = {Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {7},
  pages = {114502},
  doi = {10.1016/j.celrep.2024.114502}
}
Kostenlos starten →